YOLFTbeta
XTL Biopharmaceuticals Ltd ADR

XTL Biopharmaceuticals Ltd ADR

XTLB · NASDAQ · Healthcare / Biotechnology

1.60USD-0.04 (-2.44%)

Price History

Full chart

Market Stats

Previous Close1.64
Open1.62
Day Range1.54 – 1.73
52-Week Range2.01 – 10.28
Volume6.00K
Market Cap5.43M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.36
Dividend Yield0.00%
Beta0.45
50-Day Avg2.65
200-Day Avg2.83

About

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Herzliya, Israel.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Noam Band
  • Employees4
  • Headquarters85 Medinat Hayehudim St., Herzliya, Israel, 4676670, USA
  • Websitehttps://www.xtlbio.com

Leadership

  • Mr. Noam BandCEO & Director · b. 1970
  • Mr. Segal Niv CPAChief Financial Officer · b. 1986

Financials

Income Statement

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---3.45M3.20M454.00K907.00K5.94M---938.00K2.37M41.00K-6.00K23.00K29.00K52.00K69.00K28.00K1.47M-459.00K0451.00K0
Growth (%)-----7.44%-85.80%+99.78%+554.91%----+152.56%-98.27%-114.63%+483.33%+26.09%+79.31%+32.69%-59.42%+5135.71%-131.31%+100.00%--100.00%
Cost of Revenue---3.30M2.80M54.00K110.00K-5.63M---380.00K741.00K177.00K3.00K1.00K0-1.00K1.00K1.00K0448.00K0
Gross Profit---153.00K400.00K400.00K797.00K5.94M---558.00K1.63M-17-13.00K20.00K28.00K52.00K69.00K-1.00K-1.00K-1.00K03.00K0
Gross Margin---4.43%12.51%88.11%87.87%100.00%---59.49%68.72%-0.04%216.67%86.96%96.55%100.00%100.00%-3.57%-0.07%0.22%-0.67%-
Operating Expense---16.93M14.78M16.45M26.53M15.53M---2.91M4.52M2.02M3.60M2.58M1.27M845.00K911.00K947.00K1.03M879.00K765.00K2.17M1.69M
Operating Income-15.12M-17.71M14.56M-16.78M-14.38M-16.05M-25.73M-9.59M2.57M-1.26M-1.16M-2.36M-2.89M-2.02M-3.61M-2.56M-1.25M-793.00K-842.00K-948.00K-1.03M-880.00K-765.00K-2.17M-1.69M
Operating Margin----485.70%-449.80%-3534.36%-2837.38%-161.46%----251.17%-122.16%-4931.71%60183.33%-11134.78%-4296.55%-1525.00%-1220.29%-3385.71%-70.33%191.72%--481.60%-
EBITDA-15.12M-17.71M15.36M-16.46M-12.36M-15.80M-25.63M-18.40M2.58M-1.21M-1.06M-3.80M-1.10M-1.97M-2.00M-1.71M-1.25M-792.00K-268.00K-947.00K-1.03M-879.00K-764.00K-930.00K-752.00K
EBITDA Margin----476.46%-386.46%-3480.84%-2825.47%-309.80%----404.69%-46.35%-4802.44%33333.33%-7434.78%-4293.10%-1523.08%-388.41%-3382.14%-70.26%191.50%--206.21%-
Net Income-12.67M-17.14M-14.29M-16.47M-14.02M-15.13M-24.94M-9.25M2.59M-1.26M-1.21M-1.39M-2.48M-2.53M-4.31M-2.54M-781.00K2.99M-1.35M-782.00K435.00K-1.35M-1.78K-1.03M-6.97M
Net Income Margin----476.93%-438.38%-3333.04%-2749.61%-155.66%----148.19%-104.52%-6163.41%71850.00%-11065.22%-2693.10%5742.31%-1952.17%-2792.86%29.67%293.68%--227.72%-
R&D11.05M13.16M11.10M12.79M7.54M10.87M20.95M10.39M-64.00K158.00K99.00K113.00K278.00K578.00K443.00K43.00K38.00K35.00K38.00K30.00K30.00K31.00K98.00K28.00K
R&D as % of Total Revenue---370.44%235.85%2394.27%2309.81%174.88%---10.55%4.77%678.05%-9633.33%1926.09%148.28%73.08%50.72%135.71%2.05%-6.54%-21.73%-
Interest Expense-000004.00K3.00K2.00K7.00K8.00K15.00K35.00K6.00K11.00K16.00K8.00K7.00K29.00K17.00K21.00K11.00K4.00K86.00K7.00K
Interest Expense % of Total Revenue---0.00%0.00%0.00%0.44%0.05%---1.60%1.48%14.63%-183.33%69.57%27.59%13.46%42.03%60.71%1.43%-2.40%-19.07%-

Balance Sheet

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets55.11M38.42M24.85M25.62M15.15M26.90M14.13M3.43M715.00K3.80M4.07M11.09M8.02M5.64M5.32M3.02M6.59M8.57M7.21M6.50M6.62M4.19M2.43M8.55M166.00K
Total Liabilities-3.59M4.25M6.02M3.90M4.14M5.56M2.00M708.00K963.00K629.00K1.66M1.23M965.00K436.00K330.00K2.97M253.00K232.00K254.00K1.28M187.00K206.00K3.12M420.00K
Total Equity51.95M34.83M20.61M19.60M11.25M22.76M8.56M1.43M7.00K2.83M3.44M7.35M6.26M4.66M4.89M2.69M3.62M8.32M6.98M3.61M5.33M4.00M2.22M5.43M-254.00K
Cash--4.18M12.79M13.36M4.40M2.38M2.92M412.00K1.07M123.00K1.70M2.89M2.16M3.82M2.02M3.29M3.25M4.46M3.63M2.97M2.09M1.40M371.00K76.00K
Total Debt------3.81M1.06M---------------138.00K269.00K
Net Debt---4.18M-12.79M-13.36M-4.40M-2.38M-2.92M-412.00K-1.07M-123.00K-1.70M-2.89M-2.16M-3.82M-2.02M-3.29M-3.25M-4.46M-3.63M-2.97M-2.09M-1.40M-233.00K193.00K

Cash Flow

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-13.33M-14.49M-10.47M-12.59M-21.46M-10.58M-2.49M-735.00K-1.80M-1.51M-2.50M-2.47M-1.86M-1.73M-1.13M-816.00K-908.00K-850.00K-1.05M-901.00K-707.00K-1.62M-1.02M
Investing Cash Flow15.49M7.65M9.53M-20.83M10.64M10.91M-24.00K-103.00K-185.00K-1.21M3.34M1.50M-110.00K-66.00K-2.50M778.00K2.11M32.00K8.00K36.00K41.00K-844.00K522.00K
Financing Cash Flow4.00K15.45M1.51M24.46M8.80M210.00K-1.48M1.74M4.28M317.00K309.00K3.58M04.89M385.00K385.00K385.00K385.00K001.45M208.00K
Capital Expenditure81.00K180.00K38.00K21.00K65.00K2.00K016.00K12.00K86.00K84.00K10.00K66.00K66.00K2.00K2.00K2.00K1.00K00054.00K0
Free Cash Flow-13.41M-14.68M-10.50M-12.61M-21.52M-10.58M-2.49M-751.00K-1.81M-1.59M-2.58M-2.48M-1.93M-1.80M-1.13M-816.00K-910.00K-851.00K-1.05M-901.00K-707.00K-1.67M-1.02M
FCF to OCF100.61%101.24%100.36%100.17%100.30%100.02%100.00%102.18%100.67%105.71%103.36%100.40%103.55%103.81%100.00%100.00%100.22%100.12%100.00%100.00%100.00%103.34%100.00%

Earnings

Report DateSep 7, 2009Dec 2, 2009Mar 18, 2010Jun 2, 2010Sep 6, 2010Dec 1, 2010Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Nov 27, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 1, 2015Sep 1, 2015Dec 1, 2015Mar 31, 2016Jun 1, 2016Sep 27, 2016Dec 6, 2016Mar 30, 2017Jun 15, 2017Sep 26, 2017Nov 27, 2017Mar 15, 2018Jun 11, 2018Jul 24, 2018Dec 19, 2018Mar 31, 2019Apr 16, 2019Sep 24, 2019Dec 3, 2019Mar 12, 2020May 27, 2020Jul 21, 2020Dec 8, 2020Mar 18, 2021May 31, 2021Jul 27, 2021Dec 7, 2021Mar 17, 2022Jun 1, 2022Jul 26, 2022Dec 6, 2022Mar 16, 2023May 31, 2023Jul 25, 2023Dec 5, 2023Mar 14, 2024Apr 30, 2024Jul 23, 2024Dec 3, 2024Mar 13, 2025Apr 30, 2025Dec 30, 2025
EPS Estimate-------------------------0.20--------0.00---0.00--------------0.000.000.000.000.000.00----0.000.00
EPS Actual8.430.06-1.67-2.40-1.98-0.81-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.000.000.95-0.00-0.00-0.00-0.00-0.00-0.06-0.02-0.02-0.04-0.04-0.00-0.10-0.00-0.000.000.310.000.000.000.000.010.01-0.01-0.000.00-0.00-0.00-0.000.00-0.00-0.00-0.150.400.01-0.05-0.15-0.14-0.17-0.07-0.04-0.050.09-0.13-0.04-0.120.00-0.01
Surprise------------------------90.00%---------------------------------------
Timing----------------------Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours------------------------Pre-market-----

Key Statistics & Ratios

Market Cap5.43M
Enterprise Value5.99M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales5.77
Price / Book1.90
EPS-0.36
Book Value0.00
Revenue (TTM)968.00K
Gross Profit (TTM)-2.25M
EBITDA-1.27M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-29.30%
Return on Assets-21.01%
Shares Outstanding2.46M
Shares Float1.75M
Beta0.45
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.21%
Insiders
21.44%
Retail / Other
78.35%

Top Institutional Holders

  • Rhumbline Advisers
    5.99K0.24%
  • GAMMA Investing LLC
    1.21K0.05%
  • Tower Research Capital LLC
    2440.01%
  • Morgan Stanley - Brokerage Accounts
    100.00%
  • Noked Israel Ltd
    00.00%
  • XTX Topco Ltd
    00.00%
  • SmartHarvest Portfolios, LLC
    00.00%
  • Citadel Advisors Llc
    00.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    1.44K0.06%

Stock Splits

  • Mar 25, 20261:4
  • Feb 10, 20171:5
  • Oct 4, 20121:10